Alina Diana Zamfir | Biomedical and Healthcare Applications | Best Researcher Award

Prof. Alina Diana Zamfir | Biomedical and Healthcare Applications | Best Researcher Award

Professor |  National Institute for R&D in Electrochemistry | Romania

Prof. Dr. Alina D. Zamfir is a leading Romanian scientist recognized internationally for her pioneering research in mass spectrometry, glycomics, proteomics, and structural biology. She currently holds dual appointments as Senior Scientific Researcher at the National Institute for Research and Development in Electrochemistry and Condensed Matter Research, Timisoara, and as Professor at Aurel Vlaicu University of Arad, Romania. she has also served as a PhD Supervisor at the Faculty of Physics, West University of Timisoara, mentoring numerous young scientists in advanced analytical methodologies.Prof. Zamfir’s research has made seminal contributions to the development of advanced mass spectrometry platforms, particularly in the integration of microfluidics, ion mobility, and nanoelectrospray systems for glycoproteomics and glycolipidomics. She has been the Principal Investigator of 17 national and international projects, funded by the Romanian UEFISCDI and the European Union, focusing on the structural and functional elucidation of complex biological molecules, including gangliosides and proteoglycans. Her collaborations extend across prestigious institutions such as the University of Münster, University of Konstanz (Germany), and Clarkson University (USA), contributing significantly to global biomedical research.Author of 198 peer-reviewed publications with over 3,018 citations and an h-index of 37, Prof. Zamfir’s work has appeared in high-impact journals including Analytical Chemistry, Electrophoresis, Glycobiology, and the Journal of the American Society for Mass Spectrometry. She has also served as Guest Editor for Molecules and Frontiers in Molecular Biosciences and as President of the Romanian Society for Mass Spectrometry since 2009, promoting the advancement of analytical sciences in Romania and beyond.Through her academic leadership, editorial contributions, and innovative research, Prof. Zamfir has profoundly influenced modern bioanalytical chemistry, driving forward applications in biomarker discovery, neurodegenerative disease research, and precision medicine. Her work bridges fundamental science and societal impact, advancing both Romania’s scientific excellence and the global progress of molecular biosciences.

Profiles: Google Scholar | ResearchGate

Featured Publications

1, Zamfir, A. D. (2007). Recent advances in sheathless interfacing of capillary electrophoresis and electrospray ionization mass spectrometry. Journal of Chromatography A, 1159(1–2), 2–13. Cited By : 117

2. Zamfir, A., Vakhrushev, S., Sterling, A., Niebel, H. J., Allen, M., & Peter-Katalinić, J. (2004). Fully automated chip-based mass spectrometry for complex carbohydrate system analysis. Analytical Chemistry, 76(7), 2046–2054.
Cited By : 94

3. Sarbu, M., Robu, A. C., Ghiulai, R. M., Vukelić, Z., Clemmer, D. E., & Zamfir, A. D. (2016). Electrospray ionization ion mobility mass spectrometry of human brain gangliosides. Analytical Chemistry, 88(10), 5166–5178. Cited By : 81

4. Sisu, E., Flangea, C., Serb, A., & Zamfir, A. D. (2011). Modern developments in mass spectrometry of chondroitin and dermatan sulfate glycosaminoglycans. Amino Acids, 41(2), 235–256. Cited By : 68

5. Zamfir, A. D., Bindila, L., Lion, N., Allen, M., Girault, H. H., & Peter-Katalinić, J. (2005). Chip electrospray mass spectrometry for carbohydrate analysis. Electrophoresis, 26(19), 3650–3673.* Cited By : 66

Prof Dr. Michael Linnebacher | Healthcare Applications | Best Researcher Award

Prof Dr. Michael Linnebacher | Healthcare Applications | Best Researcher Award

Prof Doctorate at Universitätsmedizin Rostock, Germany 

Profiles

Scopus

Orcid

Summary:

Prof Dr. Michael Linnebacher, born on July 5, 1969, in Ottweiler, Germany, is a prominent researcher in molecular oncology and immunotherapy. He serves as the Laboratory and Research Director at the Clinic for General Surgery, University Medicine Rostock. Linnebacher’s career spans significant contributions to the understanding and treatment of gastrointestinal tumors, particularly focusing on immunotherapy and the role of microsatellite instability in cancer.

Education

Prof Dr. Linnebacher holds a Diploma in Biology from the University of Saarland (1996) and completed his PhD in Biology at the Technical University of Karlsruhe in 2001. His academic training includes extensive research on immunogenic neo-peptides and tumor antigens, setting a strong foundation for his career in oncology and immunotherapy.

💼 Professional Experience

  • 1996-1997: Research assistant, Heidelberg University Biochemistry Center
  • 1998-2001: PhD student, Institute of Immunology, Ruprecht-Karls-University Heidelberg
  • 2001-2005: Postdoctoral research, University Hospital Heidelberg, Department of Molecular Pathology
  • 2005-Present: Laboratory Director, Molecular Oncology and Immunotherapy, Clinic for General Surgery, University Medical Center Rostock
  • 2009: Venia legendi (Privatdozent)
  • 2010: Junior Professor for Immunology and Infectiology, University of Saarland
  • 2012: Professor for Translational Surgical Oncology and Biobanking, University of Lübeck
  • 2020-Present: Managing Director, BioBank Rostock; Member of the German Biobank Alliance

🔬 Research Interests

  • Immunotherapy and its applications in cancer treatment
  • Microsatellite instability and its role in tumor antigen development
  • Translational research in oncology
  • Biobanking and its role in cancer research and treatment

 

Publications

Peptide-stimulated T cells bypass immune checkpoint inhibitor resistance and eliminate autologous microsatellite instable colorectal cancer cells

  • Authors: Schwarz, S., Su, Z., Krohn, M., Schlosser, A., Linnebacher, M.
  • Journal: npj Precision Oncology
  • Year: 2024
  • Authors: Edelmann, M., Fan, S., De Oliveira, T., Rieken, S., Conradi, L.-C.
  • Journal: Cancer Research Communications
  • Year: 2024

Transcriptome-wide gene expression outlier analysis pinpoints therapeutic vulnerabilities in colorectal cancer

  • Authors: Mariella, E., Grasso, G., Miotto, M., Di Nicolantonio, F., Bardelli, A.
  • Journal: Molecular Oncology
  • Year: 2024

SKP2 promotes the metastasis of pancreatic ductal adenocarcinoma by suppressing TRIM21-mediated PSPC1 degradation

  • Authors: Yuan, J., Zhu, Z., Zhang, P., Gong, P., Zhang, X.
  • Journal: Cancer Letters
  • Year: 2024

A glutamatergic biomarker panel enables differentiating Grade 4 gliomas/astrocytomas from brain metastases

  • Authors: Lange, F., Gade, R., Einsle, A., Freiman, T.M., Kirschstein, T.
  • Journal: Frontiers in Oncology
  • Year: 2024